Lesson 9 - Infection in the ICU:
A Rational Approach to Ventilator-Associated Pneumonia
and Catheter-Related Infection
By Jose C. Yataco, MD; Jaime F. Avecillas, MD; and
Alejandro C. Arroliga, MD, FCCP
Read/Print This Document
Poststudy Questions
Dr. Arroliga is Professor of Medicine and Pulmonary and Critical Care Medicine Staff, Dr. Avecillas is Senior Fellow, Pulmonary and Critical Care Medicine, and Dr. Yataco is Senior Fellow, Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH.
Drs. Arroliga, Avecillas, and Yataco have disclosed no significant relationships with the companies/organizations whose products or services may be discussed within this chapter.
Lesson 10 - Chlamydia and Chronic Cardiopulmonary Disease
By Francesco Blasi, MD; Paolo Tarsia, MD; Roberto Cosentini, MD; Stefano Aliberti, MD;
Maria Pappalettera, MD; and PierAchille Santus, MD
Read/Print This Document
Poststudy Questions
Dr. Blasi is Professor of Respiratory Medicine, Drs. Pappalettera and Aliberti are Fellows, and Drs. Cosentini, Tarsia, and Santus are Assistants, Istituto di Tisiologia e Malattie dell’Apparato Respiratorio IRCCS Fondazione Policlinico, University of Milan, Milan, Italy.
Dr. Blasi has disclosed financial relationships with a commercial party. Grant information and company names appear as provided by the author.
Abbott Laboratories- speaker bureau
ALTANA Pharma - advisory committee, grant monies (from industry-related sources)
GlaxoSmithKline - advisory committee, consultant fee, speaker bureau, grant monies (from industry-related sources)
Pfizer - advisory committee, consultant fee, speaker bureau, grant monies (from industry-related sources)
Sanofi-Aventis - consultant fee, speaker bureau
Dr. Pappalettera has disclosed financial relationships with a commercial party. Grant information and company names appear as provided by the author.
GlaxoSmithKline - grant monies (from industry-related sources)
Pfizer - grant monies (from industry-related sources)
Drs. Cosentini, Tarsia, Aliberti, and Santus have disclosed no significant relationships with the companies/organizations whose products or services may be discussed within this chapter.
